The Market Aktie 130912141 / AU0000306037
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
|
28.10.2025 21:59:00
|
Why BioMarin Pharmaceutical Stock Topped the Market on Tuesday
BioMarin Pharmaceutical (NASDAQ: BMRN) reported its third-quarter earnings after market close Monday, and they were good enough to push the biotech stock almost 2% higher the following day. With that performance, the shares notched a slight beat on the bellwether S&P 500 index, which ticked up by 1.2%. For the quarter, BioMarin's revenue came in at $776 million, which was 4% higher on a year-over-year basis. Net income not according to generally accepted accounting principles (GAAP), on the other hand, dived sharply by 88% to $22 million, or $0.12 per share. Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool